Ceribell Launches Delirium Monitoring Solution
Ceribell said the commercial launch follows a successful pilot. Customers reported improved clinical decision-making and greater confidence in care decisions.
Story updates
12:08:28 PM UTC
SquawkNews
Ceribell commercially launched its delirium monitoring solution. CMS provides an NTAP of up to $2,171 per eligible Medicare patient case, effective October 1, 2026, subject to eligibility criteria and payment rules.Material DetailsContext by AI AnalystThis is an early commercial expansion following…